×

VISTA modulators for diagnosis and treatment of cancer

  • US 9,381,244 B2
  • Filed: 09/09/2013
  • Issued: 07/05/2016
  • Est. Priority Date: 09/07/2012
  • Status: Active Grant
First Claim
Patent Images

1. A method for treating a subject with cancer comprising administering to said subject an immunostimulatory combination comprising an amount of an anti-VISTA antibody or antibody fragment and a PD-1 antagonist, wherein such immunostimulatory combination elicits a synergistic effect on antitumor immunity.

View all claims
  • 3 Assignments
Timeline View
Assignment View
    ×
    ×